LanteRNA

Gothenburg, Sweden

LanteRNA provides nucleic acid label development and drug delivery process services.

$517K raised

May 2024

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has LanteRNA raised?

LanteRNA has raised $517K in total funding. The most recent round was Seed. The last funding was announced in May 2024.

Who are LanteRNA's investors?

LanteRNA's investors include Chalmers Ventures AB.

Where is LanteRNA headquartered?

LanteRNA is headquartered in Gothenburg, Sweden.

What does LanteRNA do?

LanteRNA provides nucleic acid label development and drug delivery process services.

What stage is LanteRNA at?

LanteRNA is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 6, 2024.

MLA

"LanteRNA — Funding & Investors." VCBacked, May 6, 2024, https://www.vcbacked.co/company/lanterna. Accessed July 2, 2026.

APA

VCBacked. (2024). LanteRNA — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/lanterna

Wikipedia (cite web)

{{cite web |title=LanteRNA — Funding & Investors |url=https://www.vcbacked.co/company/lanterna |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 6, 2024.